Identity
- Trade Name
- geneX® putty FDA UDI
- Generic Name
- Synthetic bone graft FDA UDI
- Device Name
- geneX® Putty consists of an inorganic framework of calcium based ions. geneX® Putty has been bioengineered to mimic human bone. It is a simple to use synthetic resorbable material designed to promote regeneration of bone in osseous defects. It degrades into component elements normally found in the body and is highly biocompatible. geneX® Putty is a non-setting putty and is supplied sterile. FDA UDI
- Model / Reference
- 920-002 FDA UDI
- Description
- geneX® Putty consists of an inorganic framework of calcium based ions. geneX® Putty has been bioengineered to mimic human bone. It is a simple to use synthetic resorbable material designed to promote regeneration of bone in osseous defects. It degrades into component elements normally found in the body and is highly biocompatible. geneX® Putty is a non-setting putty and is supplied sterile. FDA UDI
Identifiers
- Catalog Number
- 920-002 FDA UDI
- Primary DI / UDI-DI
- 15060155710164 FDA UDI
- 510(k) Number
- FDA Product Code
- MQV FDA 510(k)FDA UDI
- GMDN Term
- Synthetic bone graft FDA UDI
Classification
- Device Class
- Class II FDA 510(k)FDA UDI
- Legislation / Framework
- 21 CFR Part 888.3045 FDA 510(k)
- Regulation Number
- 888.3045 FDA 510(k)FDA UDI
- Advisory Committee
- Orthopedic FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
Single Use
Yes
Implantable
Yes
Contains Latex
No
Prescription Use
Yes
Over-the-Counter
No
Convenience Kit
No
Combination Product
No
HCT/P
No
Premarket Exempt
No
Lot / Batch Number
Yes
Serial Number
No
Expiration Date
Yes
Manufacturing Date
No
Genex Putty is a bone graft substitute classified as a bone void filler. It is designed to fill defects in bone that are not structurally critical to the spine or pelvis, providing a scaffold for natural bone regeneration during the healing process.
This non-setting putty is supplied in a malleable form to conform to surgical sites. It is intended for single-use and is regulated under FDA 510(k) clearance (K073341) as a substantially equivalent device to existing products in the orthopedic category. No sterility or MRI safety information is specified in the provided data.
Frequently asked questions
What types of bone defects is Genex Putty intended to address, and why is it not suitable for critical structural areas like the spine or pelvis?
Genex Putty is designed specifically to fill non-structurally critical bone defects, such as small voids or gaps in long bones or peripheral skeletal sites. It acts as a scaffold to support natural bone regeneration during healing. It is not intended for critical structural areas like the spine or pelvis because these regions require devices capable of maintaining mechanical integrity and load-bearing capacity, which Genex Putty does not provide.
How is Genex Putty supplied, and what does its malleable form mean for surgical use?
Genex Putty is supplied in a non-setting, malleable form, allowing it to be easily shaped and molded to conform to the contours of the surgical site. This flexibility simplifies application during procedures, ensuring it can fill irregular bone defects without requiring additional setting or hardening.
Is Genex Putty intended for single-use or repeated use, and what does this mean for clinical workflow?
Genex Putty is explicitly intended for single-use only. This means each package is designed for one surgical procedure, reducing the risk of cross-contamination and ensuring sterility is maintained for the patient. Clinicians should follow standard single-use protocols, including proper disposal after use.
Are there any specific storage requirements for Genex Putty, and if not, how should it be handled before surgery?
The provided data does not specify any special storage requirements for Genex Putty, such as refrigeration or protection from light. However, as a single-use, non-sterile (as per the data) medical device, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures. Always check the packaging for any manufacturer-recommended handling instructions before use.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: genex® Tricalcium Phosphate | Bone Healing Catalyst, genex® Bone Graft Substitute | Zimmer Biomet, GENEX PUTTY by BIOCOMPOSITES LTD. | FDA 510 (k) Summary, BIOCOMPOSITES LTD 920-010 geneX® putty - RevMed
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K073341 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biocomposites Ltd
- FDA Applicant
- Biocomposites, Ltd.
Sources (2)
- FDA 510(k) K073341 24 fields · synced Sep 19, 2026
- FDA UDI 15976f39-1029-40f9-9141-148be61b650c 38 fields · synced May 27, 2026